IRLAB Comments on Statements in Ipsen's 2022 Universal Registration Document and the Further Development of Mesdopetam

GOTHENBURG, SWEDEN / ACCESSWIRE / May 3, 2023 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, May 3, 2023 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company that discovers and develops new treatments for Parkinson's …